-
.
- fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
. . - .
/ - .
"we were quite surprised to find there were no significant differences," says study author .
318 Used Today
254 Used Today
80 Used Today
99 Used Today
110 Used Today
273 Used Today
323 Used Today
"we were quite surprised to find there were no significant differences," says study author .
218 Used Today